Navigation Links
AIDS Action Calls on Huckabee to Follow HIV/AIDS Science
Date:12/11/2007

Calls on Every Candidate from Every Party to Commit to Creating Evidence Based National HIV/AIDS Strategy

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- AIDS Action released a statement today calling on Presidential Candidate Mike Huckabee to rewrite his HIV/AIDS platform to ensure that the policies he would undertake as President conform to science-based principles and end stigma against people living with HIV. "Governor Huckabee's 1992 statement calling for the quarantine of people living with HIV was wrong on the facts and was not consistent with the science and understanding of HIV at that time," said Ronald Johnson, AIDS Action's Deputy Executive Director. "Enactment of such a policy would have resulted in driving the disease even further underground and diminished our ability to prevent new infections."

AIDS Action, along with many national organizations, has been advocating for the creation of a science-driven national AIDS strategy for the United States. "This is a very important moment in the Presidential campaign because it underscores the need for a science-based and evidence-driven national policy that is developed with the participation and input of the many affected communities," said Johnson. "We call on Governor Huckabee and every Presidential candidate to meet with the AIDS community and develop a results-oriented national AIDS strategy that can drive increased efficiency and better outcomes on HIV prevention and treatment, and reduce racial disparities in the epidemic."

More information is available at http://www.nationalaidsstrategy.org.

Currently five Presidential candidates have publicly committed to the creation of a science-based National AIDS Strategy as outlined on the website. They are: Senator John Edwards, Senator Barack Obama, Senator Hillary Clinton, Governor Bill Richardson and Representative Dennis Kucinich.

AIDS Action Council is a Washington non-profit organization that advocates on behalf of people living with HIV and AIDS and that helped to create and ensure passage of the original Ryan White CARE Act in 1990 and the Ryan White HIV/AIDS Treatment Modernization Act of 2006 last December.


'/>"/>
SOURCE AIDS Action
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Drug interactions with warfarin
2. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
5. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
6. Kaiser Permanente Achieves Climate Action Leader Status
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
9. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
10. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
11. Scientists reveal DNA-enzyme interaction with first ever real time footage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: